Browse by Hotbed/Location
Filter News
Found 526,762 articles
-
Researchers at the University of California at San Francisco have discovered that a scorpion toxin can actually be harnessed to target the wasabi receptor, which is described as a “chemical-sensing protein” found in nerve cells.
-
In Wake of Terminations, Pharma Leaders Decry Actions That Will Limit Collaborations with Foreign...
8/23/2019
Leaders from across the pharmaceutical industry are decrying negative actions taken by government agencies and universities against Chinese researchers in the United States. -
The new company, which was founded earlier this year, will take a similar approach to treat kidney disease that oncologists have taken with cancer.
-
BioSpace Movers & Shakers, Aug. 23
8/23/2019
Biopharma companies strengthen their senior leadership teams and boards of directors with this week's appointments. -
In a head-to-head study, BeyondSpring’s plinabulin stood up to Amgen’s Neulasta (pegfilgrastim) in a quality of life study to prevent neutropenia, a common side effect for chemotherapy patients.
-
Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.
-
Eli Lilly won an arbitration hearing over accusations the Indianapolis-based company misused confidential information regarding the intellectual property of its former business partner, France-based Adocia S.A.
-
Shioma Anti-Aging is Helping Men Wave Goodbye to Erectile Dysfunction with Cutting-edge GAINSWave® Treatment
8/23/2019
Phyllis Okereke, MD, FAARFM with Shioma Anti-Aging is implementing a non-invasive and drug-free solution for Erectile Dysfunction (ED
-
Parks Associates: 35% of US Consumers Ages 65+ Interested in Telehealth Services from Local Doctor
8/23/2019
Parks Associates will examine the market for IoT health solutions and current trends in the connected health market during "Connected Health: Serving Consumers at Home," the pre-show workshop for Connected Health Summit on August 27.
-
Charles Lively MD is Helping Men Wave Goodbye to Erectile Dysfunction with Cutting-edge GAINSWave® Treatment
8/23/2019
Charles Lively MD is implementing a non-invasive and drug-free solution for Erectile Dysfunction (ED).
-
Body Renaissance is Helping Men Wave Goodbye to Erectile Dysfunction with Cutting-edge GAINSWave® Treatment
8/23/2019
Jennifer Trinidad, with Body Renaissance is implementing a non-invasive and drug-free solution for Erectile Dysfunction (ED).
-
Shares of Ping An Good Doctor Jumped Nearly 50% after the Results, with Banks Maintaining a "Buy" Rating
8/23/2019
The world largest online healthcare platform, Ping An Good Doctor (01833.HK), has seen its share price rise sharply recently, closing at HK $48.35 on 23 August, up 6.73%.
-
Global Bronchiectasis Drugs Market Outlook 2019-2023 | Availability of Low-Cost Off-Label Generics to Boost Market Growth | Technavio
8/23/2019
The global bronchiectasis drugs market size is poised to grow by USD 117.57 million during 2019-2023, according to a new report by Technavio, progressing at a CAGR of close to 5% during the forecast period.
-
Nordic Nanovector ASA: Mandatory Notification of Trade - Primary Insider
8/23/2019
Malene Brondberg has today, 23 August 2019, purchased 1,722 shares in Nordic Nanovector ASA (the "Company") at an average share price of NOK 25.38 per share.
-
Antimicrobial Susceptibility Testing Market Outlook 2019 – 2023: Government Initiatives to Boost Growth | Technavio
8/23/2019
The global antimicrobial susceptibility testing market size is poised to reach USD 832.14 million by 2023, according to a new report by Technavio, progressing at a CAGR of 5% during the forecast period.
-
Errant Gene Therapeutics (EGT) Wins Major Victory in New York Court
8/23/2019
Errant Gene Therapeutics (“EGT”) announces that the New York Supreme Court Justice Barry Ostrager sanctioned Bluebird Bio, Inc. (“Bluebird”) and rejected Bluebird’s efforts to prevent EGT from proceeding with its lawsuit in Massachusetts against Bluebird CEO Nick Leschly and Bluebird’s venture capital partner, Third Rock Ventures, LLC (“TRV”).
-
Tmunity Announces Participation at Upcoming Investor Conferences
8/23/2019
Tmunity Therapeutics, Inc. announced that Usman “Oz” Azam, MD, President and Chief Executive Officer, and members of the management team plan to participate at two investor conferences in September and October 2019.
-
Tenax Therapeutics Provides Clinical Development Update
8/23/2019
Tenax Therapeutics, Inc. (Nasdaq: TENX), a specialty pharmaceutical company focused on identifying, developing and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical need, today provided an update on its on-going clinical trial of levosimendan
-
Disarm Therapeutics Announces Science Publications Elucidating Structure and Function of SARM1
8/23/2019
Disarm Therapeutics, a biotechnology company creating a new class of disease-modifying therapeutics for patients with axonal degeneration, today announced the publication of two articles in Science that significantly advance the understanding of the structure and function of SARM1, a protein that is a critical regulator of cellular degeneration, and provide further support for the centrality of the NAD+-cleavage pathway in mediating cellular degeneration across multiple species.
-
Groundbreaking Imaging Technology From HDX WILL Empowers Dental Practitioner to Reconstruct Veteran's Face
8/23/2019
Diagnosed with a squamous cell carcinoma of his nose, George Purifoy underwent a rhinectomy (excision of the nose) to remove the cancer and began radiation therapy.